Synthetic biology company developing vaccines and therapeutics using cell-free biology technology
David Mace, CEO, was previously an Entrepreneur in Residence at 8VC, where he focused on the intersection of biology and computer science. He graduated from the California Institute of Technology. Michael Jewett, CTO, is the Director of the Center for Synthetic Biology at Northwestern University and the Walter P. Murphy Professor of Chemical and Biological Engineering at Northwestern University. Matthew Delisa, CSO, is the William L. Lewis Professor at Cornell University's Smith School of Chemical and Biomolecular Engineering and Director of Cornell University's Institute of BiotechnologyBiotechnology.